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Abstract The binding of tetraphenylphosphonium (TPP+) to
EmrE, a membrane-bound, 110 residue Escherichia coli multi-
drug transport protein, has been observed by 31P cross-
polarisation^magic-angle spinning nuclear magnetic resonance
spectroscopy (CP^MAS NMR). EmrE has been reconstituted
into dimyristoyl phosphatidylcholine bilayers. CP^MAS could
selectively distinguish binding of TPP+ to EmrE in the fluid
membrane. A population of bound ligand appears shifted 4 ppm
to lower frequency compared to free ligand in solution, which
suggests a rather direct and specific type of interaction of the
ligand with the protein. This is also supported by the observed
restricted motion of the bound ligand. The observation of another
weakly bound substrate population arises from ligand binding to
negatively charged residues in the protein loop regions. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
A sub-family of ion-coupled transporters, the small multi-
drug resistance (SMR) family (also called MiniTEXANS),
seems to be rather suitable for structure^function studies
due to their small size [1,2]. Members are between 107 and
115 residues of length and have been identi¢ed in Staphylo-
coccus aureus, Escherichia coli, Klebsiella aerogenes and
Gram-negative bacteria. The protein used in this study is
the chromosomally encoded E. coli resistance protein EmrE
[3]. Being one of the smallest ion-coupled transporters and
due to its hydrophobic nature, EmrE has attracted much in-
terest [3]. It has been shown that EmrE exchanges toxic cat-
ions such as methyl viologen, ethidium, acri£avin, tetraphe-
nylphosphonium (TPP) and others in exchange for protons
and is soluble in organic solvents. The protein can be func-
tionally reconstituted into lipid membranes from organic sol-
vent mixtures. A hydrophobicity analysis predicts a structure
of four transmembrane helices as shown in Fig. 1a [4]. Trans-
mission FTIR and oriented ATR-FTIR was used to determine
the secondary structure content and orientation of secondary
structure elements in EmrE reconstituted in DMPC. A 80%
helical contents was found. Amide H/D exchange experiments
suggest a four-membered transmembrane helical bundle with
an average helix tilt angle of 27‡ [5]. Liquid-state nuclear
magnetic resonance (NMR) studies of EmrE in solvent mix-
tures support a four helical model of EmrE as well [6]. How-
ever, the length of individual helices are assigned slightly dif-
ferent compared to the hydrophobicity analysis. Especially
helix I has been elongated by an amphiphilic helical link to
helix II and the loop between helices 3 and 4 turned out to be
longer (Fig. 1a). Negative dominance studies suggest that
EmrE forms a functional trimer as judged by its reduced
ability to transport while mixing active EmrE with non-active
mutants [3,7]. Measurements of the accessibility of a series of
48 single Cys-replacements throughout the protein revealed a
hydrophobic pathway for solutes in a tightly packed protein
[8]. Binding studies of detergent solubilised EmrE support a
homotrimeric model and show that Glu-14, the only mem-
brane-buried charged residue, is required for substrate recog-
nition [9]. Recently, two structural models of the trimeric
transporter were presented. One was based on molecular dy-
namics using evolutionary conservation data [10] while the
other was obtained by extensive MD calculations based on
NMR-spectroscopic constraints [11].
A rather useful tool to obtain more speci¢c information
about substrate recognition, binding and transport is given
by solid-state NMR since it allows to study the protein as
close as possible to its native state in a lipid membrane [12^
14]. The best probe of a binding site is the ligand itself. The
e¡ects produced by the transporter on the substrate are
studied in a straightforward manner by observing the sub-
strate in the presence of the transporter. It has been shown
by Spooner et al., that observation of 13C-labelled substrate in
the binding site of the active galactose^H symport protein
GalP in its native environment, the inner membranes of E. coli,
can be achieved by magic-angle spinning (MAS) NMR
[15]. The experimental idea is to make use of the particular
conditions for cross-polarisation (CP) to discriminate bound
substrate alone. CP is a widely used technique in solid-state
NMR to transfer magnetisation from abundant nuclei such as
protons to rare nuclei such as 13C in order to enhance their
signal intensity [16]. This transfer usually takes place via di-
polar couplings and is most e⁄cient in rigid or frozen systems.
Systems with di¡erent mobility should also have di¡erent CP
characteristics, which allows to di¡erentiate between highly
mobile non-bound substrate and immobilised ligand bound
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to the membrane [15,17,18]. The theory of CP dynamics has
been studied in detail in the past [19^21].
For the study presented here the high a⁄nity substrate
TPP (KD = 10 nM [9], Fig. 1b) has been chosen in order to
make use of some natural magnetic spin properties of the 31P
nucleus such as 100% abundance, spin 1/2 and high sensitivity
which makes it convenient to observe by NMR spectroscopy.
In addition, it has other attractive features for studying trans-
port mechanisms: the protein itself does not produce a back-
ground signal and there are normally only a limited number
of 31P-containing moieties in the substrates giving rise to
NMR signals which can be easily resolved and assigned.
2. Materials and methods
2.1. Protein overexpression, puri¢cation and reconstitution
Expression and puri¢cation of EmrE was done as described previ-
ously [4,6]. Reconstitution was achieved by making use of the solu-
bility of EmrE in organic solvents. The protein was dissolved in
chloroform:methanol (1:1) and a solution of L-K-DMPC (Sigma
UK) in chloroform was added. After 30 min incubation the solution
was dried under high vacuum for some hours and rehydrated in bu¡er
(0.015 M Tris, 0.15 M NaCl, pH = 7.5). The molar protein to lipid
ratio was 1:60 and 2.5 mg of protein were used. The proteoliposomes
were pelleted, resuspended in bu¡er and layered on a linear sucrose
gradient (0^50% w/w). Centrifugation (12 h, 4‡C, 90 000Ug) in a
SW28 swinging bucket rotor (Beckman, USA) produced a layer at
25^28% w/w sucrose, indicating a homogeneously reconstituted sam-
ple (DMPC control at 17% w/w). The layer was recovered and the
sucrose removed by several washing steps in bu¡er. The sample pellet
was transferred into a 7 mm diameter zirconium MAS rotor.
To probe di¡erent protein:ligand ratios, small aliquots (3 Wl) of
TPP bromide (TPP) from a 0.07 M stock solution (Aldrich) were
added stepwise to the sample in the MAS rotor. NMR experiments
were carried out after a 30 min incubation time at 30‡C after each
titration step. During incubation the sample was set spinning to en-
sure an even distribution and good mixing of sample and ligand.
2.2. NMR experiments
All NMR experiments were performed at 161.3 MHz for 31P and
400.13 MHz for 1H on a Bruker DMX-400 spectrometer using a
Bruker 7 mm double resonance MAS probe. A proton ¢eld strength
of 55 kHz was applied for CP and proton decoupling. The ¢eld
strength applied to 31P spins was adjusted to satisfy the Hartmann^
Hahn condition for CP from protons in the sample. The same power
levels were used for making observations by direct 31P irradiation.
The CP contact time was varied between 0.1 and 5.0 ms. A repetition
delay time of 2.0 s was applied. A spinning rate of 2500 Hz was used
throughout this study and controlled to within þ 5 Hz. Observations
were made in both the LK (liquid crystalline) and LL0 (gel) phase at
30‡C and 7‡C respectively. The temperature was regulated by a
Bruker BT3000 temperature control unit. Spectra were analysed using
Felix (Biosym).
3. Results
The proton-decoupled 31P-MAS spectrum recorded from
DMPC vesicles (19.2 Wmol, 13 mg) containing 1 Wmol TPP
is shown in Fig. 2a. The spinning speed was set to 2500 Hz,
which is less than the DMPC 31P chemical shift anisotropy
and causes spinning sidebands equally separated from the
isotropic chemical shift. The TPP resonance is observed at
23.2 ppm, consistent with the literature value [22], between
sidebands +1 and +2.
Di¡erent from established applications to rigid systems,
CP^MAS is used here not for signal enhancement but merely
as a ‘dynamic ¢lter’ to observe substrate immobilised by bind-
ing to the membrane. In order to achieve this, the membrane
has to remain in the £uid state (above 273 K). CP should then
be incapable of detecting non-associated substrate due to the
motional averaging of dipolar coupling in solution [15]. The
CP^MAS spectrum in Fig. 2b does not contain any signal
from TPP. CP fails to detect the substrate, which means
TPP is not immobile in the £uid DMPC membrane and
undergoes isotropic tumbling instead.
Fig. 2c shows a proton-decoupled 31P-MAS spectrum of
DMPC proteoliposomes containing 0.2 Wmol EmrE (2.5 mg)
at a lipid:protein ratio of 60:1 with 0.5 Wmol TPP. In con-
trast to the spectrum in Fig. 2b, CP reveals two signals of
di¡erent intensities at frequencies of 22.9 ppm (TPP-1) and
19.0 ppm (TPP-2) (Fig. 2d). Since the substrate can be ob-
served by CP it must be immobilised on the relevant NMR
time-scales (ms), which can best be explained by binding to
the protein. Both observed TPP chemical shifts changed by
30.3 ppm (TPP-1) and 34.2 ppm (TPP-2) compared to the
substrate in solution. Especially the shift for TPP-2 is of sig-
ni¢cant size and points toward a direct interaction between
ligand and protein.
The membrane dynamics can be probed qualitatively by
studying CP build-up curves for di¡erent membrane compo-
nents as shown in Fig. 3. Lipids are highly mobile. Their
dynamics in a liquid^crystalline membrane is characterised
by internal motions (trans-gauche isomerisation, djV10311s),
intermolecular motions (rotational di¡usion about long axis
dReV10310 s, and wobbling of long axis dRPV1039 s) and
collective motions where the whole membrane undergoes un-
dulations (1033T1036 s) [23,24]. Therefore, 1H^31P dipolar
couplings are reduced and CP is rather ine⁄cient. A long
contact time of 5 ms is needed to reach an optimum signal
intensity as shown in Fig. 3b after which the intensity slowly
decays. The observed £uctuations within the ¢rst 0.5^1 ms are
typical for CP build-up curves of dynamic molecules such as
Fig. 1. Fold of EmrE protein predicted by hydropathy plots [3] and
as analysed from liquid-state NMR data (dotted lines) [6] (a).
Charged residues are labelled. EmrE is an E. coli multidrug trans-
porter that removes a variety of toxins in exchange for hydrogen
ions. The toxin used in this study is TPP. TPP also binds to
BmrR, a transcription activator of a multidrug transporter, whose
crystal structure in the presence and absence of TPP is known
[27]. The structure of TPP in the binding site is shown here (b).
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lipids in a £uid membrane. The build-up of bound TPP how-
ever is more rapid and reaches its optimum already at 1.6 ms
for TPP-1 and at 0.5 ms for TPP-2. This indicates, that TPP
while bound to EmrE is substantially less mobile than DMPC.
In addition, it can be concluded that the component TPP-2 is
less mobile than TPP-1.
The molar ratio of TPP :EmrE used here was 2.5:1. Addi-
tional experiments at di¡erent ligand:protein ratios were per-
formed. For sub-stoichioemetric quantities (0.3 mol/mol) only
one signal, TPP-1, could be observed. Its intensity did increase
by adding more substrate to the sample pellet. In contrast
however, TPP-2 appeared for TPP :EmrEs 2 mol/mol and
remained almost unchanged by adding more ligand.
4. Discussion
Our CP results demonstrate that the substrate transporter
complex exists for a lifetime, that is long on the experimental
time scale (ms). This is consistent with the known high-a⁄nity
binding of TPP to EmrE (KD = 10 nM) [9].
The most interesting result is the appearance of a TPP
signal shifted by 34.2 ppm with respect to free substrate in
solution. Chemical shifts measured in 31P NMR are related to
shielding by the electron cloud around the phosphorus nu-
cleus. Factors that in£uence the distribution of these electrons
are expected to lead to changes in the chemical shift. These
factors could be conformational changes of the molecule or
changes in its environment. Although changes in charge
should not necessarily lead to changes in the chemical shift
[25], they can be accompanied by more relevant parameters
such as bond geometry, electronegativity of substituents and
the relative amounts of Z-bindings. Another contribution is
ring-current shifts caused by binding of the phosphoryl moiety
in the vicinity of an aromatic residue. These conditions are
ful¢lled if the ligand would interact speci¢cally with the pro-
tein, causing dramatic changes in its environment and also
likely to enforce some changes in its average conformation.
It has been shown by scanning the cysteine accessibility of
EmrE, that the protein is rather tightly packed without any
continuous aqueous domain but with a hydrophobic pathway
for solutes [8]. This would indeed be required for a substrate
like TPP to interact directly with the protein causing changes
of the existing protein and substrate structure. In addition, it
has been found, that the membrane-embedded charged resi-
due Glu-14 is required for ligand binding [9]. Interestingly,
TPP also interacts speci¢cally with BmrR, a transcription
activator of the gene for the Bacillus subtilis multidrug trans-
porter Bmr [26]. There, TPP binding is mediated by van der
Waals contacts with multiple hydrophobic residues in the
pocket but mainly by an electrostatic interaction between
the positively charged substrate and Glu-134 at the bottom
of the binding site [27]. The structure of TPP while bound to
BmrR is shown in Fig. 1b. The tetrahedral symmetry of the
phosphonium ion TPP requires all bond angles to be 109.5‡.
However, the structure of the bound substrate is distorted and
all bond angles between the phenyl rings and the phosphorus
nucleus deviate between 1 and 5‡ from symmetry. It is not
unreasonable to assume, that similar structural changes would
occur for TPP, strongly bound to tightly packed EmrE, in
order to explain the relatively large chemical shift di¡erence of
34.2 ppm. A number of studies suggest that bond angle dis-
tortion e¡ects are most important in order to explain 31P
chemical shift di¡erences although they are also inseparably
intermixed with electronegativity and Z-electron overlap ef-
fects [28]. In our case, phenyl can act as a Z-electron donor
to the empty 3d orbitals of phosphorus in the phosphonium
compounds and so conformational changes would contribute
here as well to these e¡ects. 31P chemical shift changes of
phosphate moieties in substrates and inhibitors so far mea-
sured in complexation with enzymes are usually less than
2 ppm, but changes of 4^5 ppm have been detected [29].
The largest enzyme-associated 31P perturbation is the obser-
vation that the phosphate covalently bound to alkaline phos-
phatase is shifted 6^8 ppm down-¢eld from inorganic phos-
phate in solution [30^32]. It has been suggested that a shift in
the pK of the phosphate as well as bond-angle strain in the
enzyme complex account for this e¡ect [31]. The precise con-
formation of TPP bound to EmrE cannot be derived just
based on chemical shift changes, but it can be concluded
that TPP-2 is actually the substrate strongly bound in the
binding pocket.
It is now necessary to explain origin and potential meaning
Fig. 2. 31P-MAS spectrum under 1H decoupling of DMPC with added TPP (DMPC:TPP = 20:1 mol/mol) (a). The isotropic lines are labelled
with TPP (23.2 ppm) and DMPC (30.7 ppm). The indices 32, 31, +1, +2 denote DMPC spinning sidebands. Under 1H^31P CP (here shown
for 0.6 ms contact time), no TPP could be detected in the DMPC sample (b). The proton decoupled 31P-MAS spectrum of DMPC vesicles
containing 0.2 Wmol EmrE (2.5 mg) at a lipid:protein ratio of 60:1 with 0.5 Wmol TPP (c) shows no signi¢cant di¡erence to spectrum (a), but
under CP two additional resonances (1 = 22.9 ppm, 2 = 19.0 ppm) appear (d). All spectra were acquired at 161.3 MHz for 31P, T = 280 K and
sample rotation rate gr = 2500 Hz. The chemical shift is referenced with respect to H3PO4 (85% solution).
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of the other observed bound TPP population (TPP-1). Its
chemical shift changes only by 30.3 ppm. This means, that
only small structural and/or environmental changes occur. As
concluded from our control experiments (Fig. 2a,b), no non-
speci¢c binding to the lipids is detected. Therefore, it must
also bind to the protein. However, TPP-1 is motionally less
restricted than TPP-2 in the binding pocket judging from the
CP build-up curves. A possible explanation is that low-a⁄n-
ity, non-speci¢c binding to charged residues in the hydrophilic
loop regions takes place. EmrE contains ¢ve cationic residues
(Lys-22, Arg-29, Arg-82, Arg-106, His-110) and three carbox-
ylates (Glu-14, Glu-25, Asp-84) as shown in Fig. 1a. Only
Glu-14 is predicted to be membrane-embedded whilst all other
residues are expected to be accessible from the solvent. It is
therefore feasible that TPP binds via electrostatic interac-
tions to the negatively charged residues Glu-25 and Asp-84.
This binding would not cause essential chemical shift changes
and TPP would be motionally less restricted since it is not
bound into a tight binding pocket. The question of course is,
whether this additional substrate binding is actually required
for transport or whether it is a less important side-e¡ect. It is
interesting to note, that the signal intensity of TPP-1 did in-
crease with titrating substrate into the sample pellet but TPP-2
just appeared from TPP :EmrEs 2 mol/mol and remained
almost unchanged which hints toward a functional mecha-
nism. The crystal structure of transcription factor BmrR
with and without bound TPP reveals a drug-induced unfold-
ing and relocation of an K helix, which exposes an internal
drug-binding pocket. It has been argued that the ligand TPP
induces these structural changes by interactions with charged
residues [27]. A similar cooperative process could take place
here. In that case, EmrE would be oriented in the membrane
with both N- and C-terminal pointing into extracellular space,
while the carboxylates Glu-25 and Asp-84 on the opposite
side are required to interact with the substrate prior its trans-
location out of the cell (Fig. 1a). This assumption is supported
by a recent computational model of EmrE representing a
closed form of the ion coupled transporter [11]. The negative
charge of the central Glu-14 is exposed to the same side as
Glu-25 and Asp-84, indicating that this side may indeed be
intracellular. The charge distributions of the putatively intra-
cellular side is shown in Fig. 4. The proximity of the residues
Glu-25 and Asp-84 in this model suggest that the ligands are
attracted by these residues, constituting a weak binding site.
Weak binding to these positions might lead to an unfolding of
a short amphiphilic helix which connects helix I and II in the
model. This helix is part of a lid that closes the intracellular
side of the protein, partially shielding Glu-14. Such an helix
Fig. 4. Simulated charge distribution of EmrE viewed from puta-
tively intracellular side (for details see [11]). The negatively charged
residues Glu-25 and Asp-84 are located on the protein surface al-
lowing weak binding of TPP. Strong binding is mediated by Glu-
14 buried inside the hydrophobic core of EmrE.
Fig. 3. 31P-CP MAS spectra of EmrE/DMPC (1:60) containing TPP at di¡erent contact times (a). The CP pro¢le for the isotropic DMPC sig-
nal and both observed TPP resonances reveals that the best polarisation transfer for the lipid takes place at longer contact times, while the
optimum for TPP1 is observed at 1.6 ms and for TPP2 at 0.5 ms. The dotted lines are of no theoretical signi¢cance.
FEBS 24031 28-8-00 Cyaan Magenta Geel Zwart
C. Glaubitz et al./FEBS Letters 480 (2000) 127^131130
unfolding event would compare to the structural changes ob-
served in BmrR.
Replacing each one of the carboxyl residues Glu-25 and
Asp-84 in the loops with Cys has no e¡ect on the activity
of the transporter. Replacement of both carboxylates, how-
ever confers decreased resistance in vivo and shows only mar-
ginal transport activity in proteoliposomes [33]. In contrast,
TPP binding to the double mutant takes place with nearly the
same a⁄nity as to the wild type [34], which points toward a
more indirect or even no involvement of the carboxylates in
substrate recognition. Further biochemical as well as NMR
investigations are required in order to understand the role of
Glu-25 and Asp-84 better.
It shall be pointed out, that our observations here do not
contradict previous biochemical studies. Binding studies of
observed 3H-TPP to detergent solubilised EmrE- His sug-
gested 0.25^0.3 mol of TPP per mol of EmrE bound with
a KD of 10 nmol [9]. Detergent e¡ects could alter the possi-
bility of weak substrate binding to the protein surface so that
only substrate in the binding pocket is detected. In addition
low a⁄nity binding might be di⁄cult to detect with radio-
active ligands.
It is not trivial to analyse the stoichiometry in the presented
study, since the precise correlation between observed CP in-
tensities for DMPC, TPP-1, TPP-2 and their concentration
depends on a number of factors such as dynamics and CP
contact time. It is however save to conclude that the molar
quantity of substrate contributing to TPP-1 is actually larger
than the strongly bound population of TPP-2 (Fig. 3). Assum-
ing the same CP e⁄ciency for both TPP-1 and TPP-2, their
intensity ratio can be interpreted as as molar ratio of between
4:1 and 6:1. This observations would be consistent with the
recently presented computational model of EmrE [11]. The
surface-exposed negatively charged residues Glu-25 and Asp-
84 would allow weak binding to more molecules than Glu-14
which is buried in a tight hydrophobic pore in the centre of
the trimer, mediating strong substrate binding (Fig. 4).
5. Conclusions
In this study, the cationic lipophilic substrate TPP has
been observed bound to EmrE by 31P-CP^MAS NMR spec-
troscopy. The large chemical shift di¡erence of 34.2 ppm and
the observed CP build-up pro¢le suggest a rather speci¢c and
direct interaction of the ligand with the protein. The observa-
tion of another weakly bound substrate population is inter-
preted as ligand binding to negatively charged residues in the
protein loop regions.
The results demonstrate a rather promising approach to
study multi-drug transport systems close to their native state
and encourage more detailed solid-state NMR studies in com-
bination with isotope labelling towards an understanding of
substrate binding and transport.
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